Cargando…
Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial
BACKGROUND: Adverse drug events could often be prevented. One of their main causes is that patients rarely know how to detect them. Another cause is inadequate communication between patients and physicians. If patients were to be effectively trained in detecting and reporting adverse drug events, th...
Autores principales: | Keriel-Gascou, Maud, Buchet-Poyau, Karine, Duclos, Antoine, Rabilloud, Muriel, Figon, Sophie, Dubois, Jean-Pierre, Brami, Jean, Vial, Thierry, Colin, Cyrille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689059/ https://www.ncbi.nlm.nih.gov/pubmed/23782470 http://dx.doi.org/10.1186/1748-5908-8-69 |
Ejemplares similares
-
Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial
por: Buchet-Poyau, Karine, et al.
Publicado: (2021) -
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019) -
IN.PACT™ Admiral™ drug-coated balloons in peripheral artery disease: current perspectives
por: Torii, Sho, et al.
Publicado: (2019) -
Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study
por: Brodmann, Marianne, et al.
Publicado: (2022) -
Three-Year Results of the IN.PACT SFA Japan Trial Comparing Drug-Coated Balloons With Percutaneous Transluminal Angioplasty
por: Soga, Yoshimitsu, et al.
Publicado: (2020)